ROSGQ OTC
Rosetta Genomics Ltd.
1W: +0.0%
1M: +0.0%
3M: +9900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$10M
+38.8% ▲
Capital Expenditures
$223K
+18.3% ▲
5Y CAGR: +82.6%
Free Cash Flow
-$11M
+38.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-239.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11M | -$13M | -$15M | -$17M | -$16M |
| Depreciation & Amort. | $274K | $298K | $299K | $748K | $904K |
| Stock-Based Comp. | $549K | $893K | $943K | $1M | $859K |
| Change in Working Capital | -$297K | $795K | -$239K | -$3M | $4M |
| Other Non-Cash Items | $2M | $576K | -$79K | $1M | $558K |
| Operating Cash Flow | -$9M | -$11M | -$14M | -$17M | -$10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$270K | -$626K | -$247K | -$273K | -$223K |
| Acquisitions (Net) | $42K | $0 | $0 | -$2M | $0 |
| Investment Purchases | $0 | -$8M | $0 | $0 | $0 |
| Investment Sales | $3K | $0 | $17K | $0 | $0 |
| Other Investing | $45K | $10K | -$28K | $7M | $1M |
| Investing Cash Flow | -$225K | -$8M | -$258K | $4M | $823K |
| — Financing Activities — | |||||
| Net Debt Issuance | $272K | $0 | $0 | $0 | -$28K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $3M |
| Financing Cash Flow | $39M | $5M | $5M | $17M | $3M |
| Net Change in Cash | $30M | -$14M | -$9M | $5M | -$6M |
| Cash End of Period | $31M | $17M | $8M | $12M | $6M |
| Free Cash Flow | -$9M | -$11M | -$14M | -$17M | -$11M |